Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...

Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune ...

Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping ...

Oral cancer is a major health challenge in India, where tobacco and areca nut use contribute substantially to the disease burden. Despite advances in surgery, chemotherapy and radiotherapy, treatment ...

Researchers at the University of California, Los Angeles have developed a compact, cost-effective diagnostic platform ...

AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research shows these systems can infer patient demographics from pathology slides, ...

The Blackstone president and his wife are funding a new Penn institute that uses AI and biomarkers to intercept hereditary cancers at their earliest stages.

AI‑guided analysis surfaces a new CAR T target with multi‑cancer activity, as Penn researchers validate GPNMB‑directed CAR T cells in preclinical models.

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based ...